4.7 Letter

Randomized, controlled trial of irinotecan plus infusional, bolus, or oral fluoropyrimidines in first- line treatment of metastatic colorectal cancer: Updated results from the BICC-C study

Journal

JOURNAL OF CLINICAL ONCOLOGY
Volume 26, Issue 4, Pages 689-690

Publisher

AMER SOC CLINICAL ONCOLOGY
DOI: 10.1200/JCO.2007.15.5390

Keywords

-

Categories

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available